MRK


Merck’s KEYTRUDA-LENVIMA Combo Bags Second Approval in Japan

This article was originally published on TipRanks.com Merck (NYSE: MRK) has announced that the Japanese Ministry of Health, Labour and Welfare has given permission …

Merck Posts Upbeat Q4 Results, Earnings Guidance Disappoints

This article was originally published on TipRanks.com American multinational pharmaceutical company Merck (NYSE: MRK) has posted better-than-expected results for the fourth quarter of 2021 on …

Merck Gets First Approval in Japan for KEYTRUDA + LENVIMA

This article was originally published on TipRanks.com Merck (NYSE: MRK) has received first-ever approval from Japanese Ministry of Health, Labour and Welfare (MHLW) for the …

Merck & Ridgeback’s Molnupiravir Receives Special Emergency Approval in Japan

This article was originally published on TipRanks.com Global pharmaceutical major Merck & Co.

FDA Grants Emergency Use Authorization to Merck’s COVID-19 Treatment

This article was originally published on TipRanks.com.

Merck & Ridgeback to Supply Additional Courses of Molnupiravir to UK

This article was originally published on TipRanks.com Global pharmaceutical major Merck & Co.

Merck Strikes Deal to Provide Molnupiravir to Canadian Government

This article was originally published on TipRanks.com Pharmaceutical company Merck (MRK) has entered a deal with the Government of Canada to provide one million …

FDA Approves Merck’s KEYTRUDA

This article was originally published on TipRanks.com Merck (MRK), an American multinational pharmaceutical company, announced that the U.

FDA Committee Votes in Favor of Merck’s COVID-19 Pill

This article was originally published on TipRanks.com Merck (MRK) and Ridgeback Biotherapeutics revealed that the U.

Merck Completes Acquisition of Acceleron Pharma

Merck (MRK) revealed that it has completed the acquisition of Acceleron Pharma Inc. (XLRN) through its subsidiary Astros Merger Sub, Inc.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts